Patients and methods The LDH levels and the isoenzymatic distribution were examined in the serum and CSF of 58 patients with primary benign tumours (n = 12), primary malignant tumours (n = 15), cerebral intraparenchymatous metastases (n = 21), and pulmonary carcinomatous meningitis (n = 4).
The isoenzymatic distribution of lactate dehydrogenase (LDH) in patients with brain tumours was previously examined in serum, ' All the examinations were performed under similar conditions. The fluid was examined immediately after lumbar puncture procedure or was frozen in -70°C. The enzymatic activities of LDH in the serum and CSF were measured by centrifuchen analyser model 500 with kits of Boehringer Mannheim GmbH, West Germany. Relative activity from the various bands were examined by densitometer scanning Quick Quant II T Helena laboratories.
The statistical analyser employed methods of one way analysis of variance, pair-wise comparisons among groups (Benferroni test) and correlation with variables (Pearson).
Results
The mean ratio of LDH 1 to LDH 2 in CSF was found to be less than one in patients with carcinomatous meningitis, 0-653 (0-24), and in patients with cerebral metastases, 0-82 (0 109). In patients with primary benign or malignant tumours, as well as in all patients of the control group, the CSF-LDH 1/LDH 2 ratios were greater than one (table) .
The CSF-LDH 1/LDH 2 ratio was found to be significantly smaller in carcinomatous meningitis and intraparenchymatous brain metastases compared to all other groups (p < 0-001). The CSF-LDH 1/LDH 2 ratio in carcinomatous meningitis was significantly smaller than in secondary brain tumours (p < 0 005). The CSF-LDH 1/LDH 5 ratio was found to be significantly smaller in in all other groups (p < 0-001).
The patients with carcinomatous meningitis had repeated CSF examinations at the beginning and the follow up period. In three out of four patients, the CSF-LDH 1/LDH 2 ratios at the initial stage of the disease were smaller than one. The CSF-LDH 5 ratios were normal and the cytopathological findings were negative. Subsequently, six weeks later the CSF-LDH 1/LDH 2 ratios continued to be smaller than one but the CSF-LDH 1/LDH 5 ratios became pathological and the cytological examinations ofthose samples were found to be positive. In the fourth patient, the ratio CSF-LDH 1/LDH 5 was greater than 15% and the cytological examination was positive at the first CSF examination. No extra fractions near the LDH 2 and LDH 3 locations12-14 were found. The serum LDH levels and their isoenzymatic pattern were normal in all samples. In this study, the ratio LDH 1/LDH 2 < 1 was found to be significant for carcinomatous meningitis and intraparenchymatous brain metastases. This finding led us to the presumption that a similar mechanism is involved in both disorders. The mechanism is probably related to the infiltration of the leptomeningeal system of malignant cells in carcinomatous meningitis as well as in secondary brain tumours. It is worth noting that in three out of four patients with carcinomatous meningitis, the CSF-LDH 1/ LDH 2 ratio changings preceded changes in the LDH 1/LDH 5 ratio and the evidences of malignant cells in the cytological CSF examinations.
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